MB

MPM BioImpact Portfolio holdings

AUM $577M
This Quarter Return
+27.19%
1 Year Return
+8.33%
3 Year Return
+241.63%
5 Year Return
+127.38%
10 Year Return
–
AUM
$497M
AUM Growth
+$497M
Cap. Flow
+$70.4M
Cap. Flow %
14.17%
Top 10 Hldgs %
64.94%
Holding
41
New
10
Increased
17
Reduced
1
Closed
7

Top Buys

1
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
$31M
2
MLTX icon
MoonLake Immunotherapeutics
MLTX
$15.1M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$11.6M
4
XERS icon
Xeris Biopharma Holdings
XERS
$10.4M
5
KALV icon
KalVista Pharmaceuticals
KALV
$6.85M

Top Sells

1
PRVB
Provention Bio, Inc. Common Stock
PRVB
$28.3M
2
INBX
Inhibrx, Inc. Common Stock
INBX
$22.5M
3
QURE icon
uniQure
QURE
$7.01M
4
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
$5.06M
5
ARQT icon
Arcutis Biotherapeutics
ARQT
$2.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRDN icon
26
Viridian Therapeutics
VRDN
$1.59B
$6.07M 1.22%
+255,323
New +$6.07M
EWTX icon
27
Edgewise Therapeutics
EWTX
$1.54B
$5.52M 1.11%
+712,798
New +$5.52M
ADAP
28
Adaptimmune Therapeutics
ADAP
$13.9M
$4.71M 0.95%
+5,095,912
New +$4.71M
OLMA icon
29
Olema Pharmaceuticals
OLMA
$432M
$4.18M 0.84%
+462,500
New +$4.18M
PHAT icon
30
Phathom Pharmaceuticals
PHAT
$843M
$4.04M 0.81%
282,332
+69,717
+33% +$998K
HARP
31
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$2.27M 0.46%
3,196,707
– –
INZY
32
DELISTED
Inozyme Pharma
INZY
$1.82M 0.37%
326,921
+93,193
+40% +$519K
VTYX icon
33
Ventyx Biosciences
VTYX
$184M
$1.04M 0.21%
+31,747
New +$1.04M
ONCR
34
DELISTED
Oncorus, Inc.
ONCR
$96.3K 0.02%
2,377,031
– –
ARQT icon
35
Arcutis Biotherapeutics
ARQT
$1.91B
– –
-254,137
Closed -$2.8M
BDTX icon
36
Black Diamond Therapeutics
BDTX
$164M
– –
-144,888
Closed -$274K
QURE icon
37
uniQure
QURE
$954M
– –
-348,224
Closed -$7.01M
TECX
38
Tectonic Therapeutic, Inc. Common Stock
TECX
$305M
– –
-647,918
Closed -$648K
TCRR
39
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
– –
-3,370,982
Closed -$5.06M
PRVB
40
DELISTED
Provention Bio, Inc. Common Stock
PRVB
– –
-1,173,809
Closed -$28.3M
INBX
41
DELISTED
Inhibrx, Inc. Common Stock
INBX
– –
-1,192,281
Closed -$22.5M
1
2